Gamida Cell - Cord Blood Transplant

Press Releases - 2004

Gamida-Cell Reports Complete Safety and Efficacy Results of Phase I/II Study of StemEx® for the Treatment of Leukemia
Dec. 6, 2004

Gamida-Cell's Phase I/II IND Study Results Indicate StemEx® for the Treatment of Leukemia to be Safe & Efficacious
Nov. 15, 2004

Gamida-Cell to Present Phase I/II Study Results of StemEx® for the Treatment of Leukemia in an Oral Presentation at the 2004 Annual Meeting of the American Society of Hematology (ASH)
Oct. 28, 2004

Gamida-Cell’s Pre-Clinical Study Demonstrates that Expanded Populations of Human Bone Marrow Stem Cells May Effectively Treat Heart Attacks Results to be presented on September 30th, 2004, 2 p.m. at Bio Japan, at the New Takanawa Prince Hotel in Shinagawa, Tokyo
Sep. 21, 2004

Gamida-Cell Completes Enrollment in its Phase I/II Trial of StemEx® for the Treatment of Leukemia
Aug. 2, 2004

Gamida-Cell To Present Stem Cell Therapy: From Vision to Therapeutics, Multiple Uses for Cord Blood Bank Units
Jun. 15, 2004

Gamida-Cell’s Groundbreaking Stem Cell Expansion Study Results to be Published in June Issue of Experimental Hematology
Jun. 3, 2004

Gamida-Cell’s Early Pre-clinical Studies Indicate Expanded Population of Stem Cells Successfully Reverses Diabetes
May. 27, 2004

Gamida-Cell Awarded $1.3 Million Grant From the Office of the Chief Scientist of the Ministry of Industry, Trade and Labor, Israel (OCS)
May. 17, 2004

Gamida-Cell TEPA Study Results Provide More Strong Scientific Support for the Company’s Current Phase I/II Leukemia Trial in the U.S.
May. 10, 2004

Gamida-Cell Study Data Shows that Expanded Populations of Stem Cells Are Efficient in Treating Heart Disease
Apr. 28, 2004

Press Releases Archive

Recent
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003

To learn more about our products and clinical trials, please fill in:
Name: 
Email: 
Country: 
* Message: